IndraLab
Statements
reach
"Next, to evaluate a potential interplay between mutant BRAF-induced ERK1/2 signaling and BMP-induced SMAD signaling pathways in the melanoma, we analyzed patient survivals as a function of high versus low expression of BMP1, BMP2, and BMP6 in two patient groups: BRAF mutant and BRAF-wildtype."
reach
"Accordingly, the present data show an inverse correlation between the activities of MEK-ERK-RSK signaling and AMPK in BRAF V600E CRC cells, suggesting that BRAF mutations activate phospho-MEK, Erk, and p90RSK without activating AMPK (XREF_FIG upper panel) and that inhibition of BRAF using selective BRAF inhibitors leads to inactivation of phospho-MEK, Erk, and p90RSK and activation of AMPK (XREF_FIG lower panel)."
reach
"Ikenoue et al. [XREF_BIBR] indicated that the BRAF mutations of CRC can promote the activation of ERK, which activates downstream transcription factors to induce a range of biochemical processes including cell differentiation, proliferation, growth, while acting as the inhibitor of apoptosis."
reach
"This result is consistent with the result seen in mice, again, it suggests that FAK is not involved in the regulation of KRAS-mutant CRCs.In mice, mutant BRAF-induced ERK activation is cancer stage-dependent with significantly higher levels of phosphorylated ERK in high-grade dysplasia and carcinoma (Rad et al., 2013), suggesting that different tumor stages may require different levels of p-ERK."
reach
"The current study is the first demonstration that mutant BRAF-induced activation of ERK signaling is tuneable in vivo, and by tuning ERK activation to alter the suppressive barrier, FAK regulates BRAF transforming activity.In BRAF-mutated melanoma, a complete shutdown of the MAPK pathway is necessary for significant tumor response (Bollag et al., 2010)."
reach
"This result is consistent with the result seen in mice, again, it suggests that FAK is not involved in the regulation of KRAS-mutant CRCs.In mice, mutant BRAF-induced ERK activation is cancer stage-dependent with significantly higher levels of phosphorylated ERK in high-grade dysplasia and carcinoma , suggesting that different tumor stages may require different levels of p-ERK."
reach
"10 One of the most common genetic alterations found in approximately 40-50% of melanomas is the constitutively activating mutation of the Braf serine/threonine kinase, which leads to unchecked stimulation of the mitogen activated kinase and extracellular signal regulated kinase (MEK) and extracellular signal regulated kinase (ERK) pathway."
reach
"The current study is the first demonstration that mutant BRAF-induced activation of ERK signaling is tuneable in vivo, and by tuning ERK activation to alter the suppressive barrier, FAK regulates BRAF transforming activity.In BRAF-mutated melanoma, a complete shutdown of the MAPK pathway is necessary for significant tumor response ."
reach
"WNT signalling is known to play a crucial role in thyroid carcinogenesis, and several mechanisms of its deregulation have been described, including inhibition of the β-catenin degradation complex via its phosphorylation by RET/PTC, inhibition of E-cadherin expression through the MAPK/ERK pathway activated by BRAF mutations, and activation of both canonical and non-canonical Wnt pathways by RAS mutations ."
reach
"Studies have shown that the BRAF mutation can activate the MAPK/extracellular signal-regulated kinase (ERK) pathway, which in turn upregulates genes involved in glycolysis and glutaminolysis, leading to an increase in glucose and glutamine uptake and utilization in PTC cells [44]."